Lundberg Alexander L, Soetikno Alan G, Wu Scott A, Ozer Egon, Welch Sarah B, Liu Yingxuan, Hawkins Claudia, Mason Maryann, Murphy Robert, Havey Robert J, Moss Charles B, Achenbach Chad J, Post Lori Ann
Buehler Center for Health Policy and Economics, Robert J Havey, MD Institute for Global Health, Northwestern University, Chicago, IL, United States.
Department of Emergency Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.
JMIR Public Health Surveill. 2025 Feb 21;11:e53214. doi: 10.2196/53214.
This study updates the COVID-19 pandemic surveillance in East Asia and the Pacific region that we first conducted in 2020 with 2 additional years of data for the region.
First, we aimed to measure whether there was an expansion or contraction of the pandemic in East Asia and the Pacific region when the World Health Organization (WHO) declared the end of the COVID-19 public health emergency of international concern on May 5, 2023. Second, we used dynamic and genomic surveillance methods to describe the dynamic history of the pandemic in the region and situate the window of the WHO declaration within the broader history. Finally, we aimed to provide historical context for the course of the pandemic in East Asia and the Pacific region.
In addition to updates of traditional surveillance data and dynamic panel estimates from the original study, this study used data on sequenced SARS-CoV-2 variants from the Global Initiative on Sharing All Influenza Data to identify the appearance and duration of variants of concern. We used Nextclade nomenclature to collect clade designations from sequences and Pangolin nomenclature for lineage designations of SARS-CoV-2. Finally, we conducted a 1-sided t test to determine whether the regional weekly speed was greater than an outbreak threshold of 10. We ran the test iteratively with 6 months of data across the sample period.
Several countries in East Asia and the Pacific region had COVID-19 transmission rates above an outbreak threshold at the point of the WHO declaration (Brunei, New Zealand, Australia, and South Korea). However, the regional transmission rate had remained below the outbreak threshold for 4 months. In the rolling 6-month window t test for regional outbreak status, the final P value ≤.10 implies a rejection of the null hypothesis (at the α=.10 level) that the region as a whole was not in an outbreak for the period from November 5, 2022, to May 5, 2023. From January 2022 onward, nearly every sequenced SARS-CoV-2 specimen in the region was identified as the Omicron variant.
While COVID-19 continued to circulate in East Asia and the Pacific region, transmission rates had fallen below outbreak status by the time of the WHO declaration. Compared to other global regions, East Asia and the Pacific region had the latest outbreaks driven by the Omicron variant. COVID-19 appears to be endemic in the region, no longer reaching the threshold for a pandemic definition. However, the late outbreaks raise uncertainty about whether the pandemic was truly over in the region at the time of the WHO declaration.
本研究更新了2020年我们首次开展的东亚及太平洋地区新冠疫情监测,并补充了该地区另外两年的数据。
第一,我们旨在衡量2023年5月5日世界卫生组织(WHO)宣布结束国际关注的突发公共卫生事件(PHEIC)时,东亚及太平洋地区的疫情是在扩大还是收缩。第二,我们使用动态监测和基因组监测方法来描述该地区疫情的动态发展历程,并将WHO宣布的时间窗口置于更广泛的历史背景中。最后,我们旨在为东亚及太平洋地区的疫情发展历程提供历史背景。
除了更新原始研究中的传统监测数据和动态面板估计值外,本研究还使用了来自全球共享流感数据倡议组织(GISAID)的新冠病毒(SARS-CoV-2)测序变异株数据,以确定关注变异株的出现和持续时间。我们使用Nextclade命名法从序列中收集分支名称,并用穿山甲命名法对SARS-CoV-2进行谱系命名。最后,我们进行了单侧t检验,以确定该地区每周的传播速度是否大于10的爆发阈值。我们在整个样本期内,以6个月的数据进行迭代测试。
在世卫组织宣布时,东亚及太平洋地区的几个国家(文莱、新西兰、澳大利亚和韩国)的新冠病毒传播率高于爆发阈值。然而,该地区的传播率在4个月内一直低于爆发阈值。在对区域爆发状态进行的滚动6个月窗口t检验中,最终P值≤0.10意味着拒绝原假设(在α=0.10水平),即2022年11月5日至2023年5月5日期间,该地区整体未处于疫情爆发状态。从2022年1月起,该地区几乎所有测序的SARS-CoV-2样本都被鉴定为奥密克戎变异株。
虽然新冠病毒在东亚及太平洋地区仍在传播,但在世卫组织宣布时,传播率已降至爆发状态以下。与其他全球地区相比,东亚及太平洋地区由奥密克戎变异株引发的疫情爆发时间最晚。新冠病毒在该地区似乎已成为地方性流行,不再达到大流行定义的阈值。然而,后期的疫情爆发引发了关于在世卫组织宣布时该地区疫情是否真的结束的不确定性。